| Date | Title | Description |
| 27.04.2026 | Vinted hits €8B valuation as EQT leads €880M secondary share sale | Vinted has completed a €880 million secondary share transaction at an equity valuation of €8 billion, with participation from a mix of new and existing investors led by EQT, Schroders Capital, and Teachers' Venture Growth.
The transaction p... |
| 12.03.2026 | Schroders Capital Launches New Digital Infrastructure Platform, Secures Data Centre Project in Ireland | Schroders Greencoat, the dedicated energy transition arm of Schroders Capital, has launched a pioneering green digital infrastructure platform and completed its initial investment in sustainable data centre development. Announced on 5 March... |
| 18.01.2026 | Schroders Capital Enhances Private Debt Capabilities with New Investment Director Appointment | In a move to enhance its existing position in the ecosystem of alternative investments, Schroders Capital has recently announced the addition of a seasoned professional to its securitized products and asset-based finance division. This appo... |
| 17.12.2025 | Schroders Capital Expands Real Estate Debt Services in Europe with Loan for Project in Sweden | Schroders Capital’s Private Debt & Credit Alternatives (PDCA) team recently announced the close of a €77 million construction whole loan for the development of a mixed-use real estate scheme in Barkarbystaden, Järfälla municipality, Gre... |
| 23.11.2025 | AgroStar Secures $30M to Expand Agri-Tech Reach | AgroStar, an Indian agri-tech startup, just raised $30 million. Just Climate led the funding round. Existing investors also participated. The money will fuel expansion, innovation, and AI development. AgroStar aims to improve farming practi... |
| 20.11.2025 | AgroStar raises $30 mn from Just Climate, existing investors | Credit: Pexels
Pune-based AgroStar, a digital farmer network and agri-inputs e-commerce platform, has raised $30 million (around Rs 265.4 crore) in equity funding from Just Climate, an investment platform set up by Generation Investment Man... |
| 19.11.2025 | Artios Pharma Secures $115M to Advance Cancer Therapies | Artios Pharma, a UK-based biotech firm, has secured $115 million in Series D funding. The financing aims to boost the development of its precision cancer treatments. Focus on DNA damage response (DDR) is key. Funds will advance clinical tri... |
| 18.11.2025 | Tata Digital-backed Curefit’s FY25 loss shrinks as revenue jumps 31% | Curefit CEO Naresh Krishnaswamy
CureFit Healthcare Pvt. Ltd, a health and digital wellness company backed by Tata Digital and several financial investors, reported operating revenue of Rs 1,216 crore for the financial year through March 202... |
| 17.11.2025 | Artios raises $115M Series D to accelerate first-in-class cancer therapies | Biotech company Artios today announced the successful close of an oversubscribed $115 million Series D financing.
Artios is pioneering next-generation approaches in the DNA damage response (DDR) field through its comprehensive anti-cancer a... |
| 17.11.2025 | €99 million Series D fuels Artios’ expansion of precision cancer treatment pipeline | Artios Pharma Limited, a British biopharmaceutical company committed to realising the therapeutic potential of targeting the DNA damage response (DDR) in cancer, today announced the successful close of an oversubscribed €99 million ($115 mi... |
| 08.11.2025 | AAVantgarde Secures $141M for Groundbreaking Gene Therapies | AAVantgarde Bio closed a $141 million Series B round. This substantial funding propels gene therapy programs for inherited retinal diseases. Key targets: Stargardt disease and Usher Syndrome Type 1B. Both represent severe conditions with no... |
| 07.11.2025 | AAVantgarde: $141 Million Series B Closed To Advance Clinical Programs For Stargardt Disease And Usher 1B Syndrome | AAVantgarde Bio has closed a $141 million (€122 million) Series B financing to advance its lead clinical programs targeting inherited retinal diseases. The financing round was co-led by Schroders Capital, Atlas Venture, and Forbion, with pa... |
| 06.11.2025 | AAVantgarde Closes $141M Series B Financing | AAVantgarde Bio, a Milan, Italy-based clinical-stage, biotechnology company developing therapies for inherited retinal diseases (IRDs), raised $141M in Series B funding.
The round was led by Schroders Capital, as well as existing investors ... |
| 23.10.2025 | Schroders Capital Receives £500M from Nest | Nest, a pension provider representing around a third of the UK workforce, has committed a further £500 million to be invested by Schroders Capital’s private markets business. The allocation strengthens the partnership which began in 2022 an... |
| 04.10.2025 | Lenskart Secures SEBI Approval for Public Market Debut The DRHP identifies SoftBank as its largest external investor with a 15.04 percent holding, followed by the Abu Dhabi Investment Authority with 1... | Omnichannel eyewear retailer Lenskart has received clearance from the Securities and Exchange Board of India (SEBI) to launch its initial public offering (IPO), according to a report by Moneycontrol.
The company's draft red herring prospect... |
| 02.10.2025 | The biggest European transportation deals in H1 2025 | In the first half of 2025, European transportation companies raised €1.5 billion across 33 deals, around 4.5 per cent of total capital and 1.7 per cent of deal activity within European tech (€33.7 billion across 1,941 deals).
Funding in tra... |
| 08.09.2025 | UK infrastructure funding set to break record highs | UK infrastructure financing deals are on track to reach a record high this year as investors compete to secure assets while the government signs off on a number of major new projects.
According to analysis from data provider Infralogic, rou... |
| 08.09.2025 | Hargreaves Lansdown and Schroders agree investment tie-up | Hargreaves Lansdown and Schroders Capital have sealed a tie-up to open up private assets opportunities to thousands more investors.
The partnership will offer access to private investments, known as long-term asset funds (LTAFs), to Hargrea... |
| 02.09.2025 | Schroders Capital Strengthens APAC Presence, Expands UK Real Estate Operations | Schroders Capital, the private markets division of global investment manager Schroders, has made significant strides in strengthening its real estate operations with a key leadership appointment in the Asia Pacific (APAC) region and a leasi... |
| 21.08.2025 | Structural Growth in GP-Led Secondaries to Reshape PE Buyout Market : Schroders Capital | Schroders Capital research finds structural growth in so-called GP-led secondaries is set to fundamentally reshape the private equity buyout market, with lower mid-market investments offering attractive opportunities
New analysis from Schro... |
| 15.08.2025 | Schroders Capital Announces Acquisition of 50% Stake in JERA Nex’s US Solar Portfolio via Schroders Greencoat | Schroders Greencoat, the specialist energy transition manager of Schroders Capital, and JERA Nex, the global renewable energy developer, are pleased to announce that Schroders Greencoat has taken “a 50% stake in JERA Nex’s US solar portfoli... |
| 28.07.2025 | Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively | • First patient dosed in global pivotal clinical trial program for late infantile/juvenile onset NPC and GM1/GM2 gangliosidoses.
• Both studies are part of Azafaros’ mission to develop treatments for the unmet need of patients with rare lys... |
| 24.07.2025 | Schroders Capital Launches New Private Equity ELTIFs | Listen to this article
0:00 / 0:04
1X BeyondWords
Schroders Capital, a private markets business of Schroders, announces the launch of additional European Long-Term Investment Funds (ELTIFs), adding to its suite of private markets solutions ... |
| 02.07.2025 | Schroders Capital Expands AI Tools with Virtual Investment Committee Agent | Listen to this article
0:00 / 0:40
1X BeyondWords
Schroders Capital, the $99.3 billion private markets division of Schroders, announces the expansion of its advanced Artificial Intelligence (AI) tools through the introduction of an innovati... |
| 19.06.2025 | Schroders Capital UK Innovation LTAF Announces Biopharma Investment | Listen to this article
0:00 / 1:02
1X BeyondWords
Schroders Capital, the $99.3bn private markets business of Schroders, announces today that its UK Innovation Long-Term Asset Fund (LTAF) has invested in Draig Therapeutics, a clinical-stage ... |
| 02.06.2025 | Schroders Capital Reportedly Raises $600M+ for Venture and Growth Fund | Listen to this article
0:00 / 0:52
1X BeyondWords
Schroders Capital, the $99.3 billion private markets business of Schroders, has successfully raised over $600 million at the final close of its Schroders Capital Private Equity Global Innova... |
| 24.05.2025 | Schroders Capital’s European Sub-IG Infrastructure Debt Strategy Raises €2B | Listen to this article
0:00 / 1:35
1X BeyondWords
Schroders Capital’s Private Debt & Credit Alternatives business announces that it has raised €2bn in total commitments from third party investors for its sub-investment grade (IG) infras... |
| 12.05.2025 | Be.EV signs £20M deal with Schroders Capital to roll out Ultra-Rapid EV chargers | UK-based EV charging network Be.EV has secured a £20 million partnership with Schroders Capital to install 200 ultra-rapid electric vehicle charging bays across 22 retail and leisure properties it manages throughout the UK.
Be.EV’s aims to ... |
| 08.05.2025 | HAYA Therapeutics: Pioneering the Future of RNA-Guided Therapies | In the world of biotechnology, innovation is the lifeblood. HAYA Therapeutics has just secured a hefty $65 million in Series A funding, a financial boost that could change the landscape of chronic and age-related disease treatment. This fun... |
| 08.05.2025 | HAYA Therapeutics banks $65 million Series A funding |
HAYA Therapeutics is a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and age-related diseases. The core of HAYA’s proprie... |
| 25.06.2024 | iOnctura's Precision Cancer Treatments Gain Momentum | iOnctura, a clinical-stage biopharmaceutical company based in Amsterdam, recently secured EUR80 million in Series B financing to accelerate the development of their lead asset, roginolisib, for the treatment of uveal melanoma and other onco... |
| 24.06.2024 | iOnctura closes EUR80 million Series B financing |
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces that it has closed an EUR80 million Series B financing. The funding round was led by new investor Syncona Limited with part... |
| 17.10.2022 | Fastned welcomes €75 million investment via Schroders Capital | Amsterdam-based fast charging infrastructure for electric vehicles developer Fastned has received a €75 million private placement of 2,032,520 new depositary receipts representing the same number of new ordinary shares in the capital of the... |
| 07.06.2022 | ImmunOs Therapeutics raises $74 Million to fund clinical trials | |
| 05.05.2022 | LOFTER GROUP partners with BentallGreenOak and Schroders Capital to acquire a redevelopment site in core Tsim Sha Tsui for Grade-A commercial development | HONG KONG, May 5, 2022 /PRNewswire/ -- LOFTER GROUP ("LOFTER" or "the Group"), a Hong Kong-based property developer, is pleased to announce the partnership with BentallGreenOak and Schroders Capital to acquire majority p... |
| 10.02.2022 | New US Laboratory and funding for HAYA Therapeutics | |
| 14.10.2021 | Schroders Institutional Investor Study 2021: Vast majority of investors will increase private assets over next 12 months amid diversification focus | The vast majority of investors plan to increase their private assets exposures over the next 12 months amid a growing focus on the benefits of diversification, Schroders Institutional Investor Study 2021* has found.
Schroders flagship annua... |
| 26.07.2021 | Schroders : Capital surpasses 330 million for its fifth European infrastructure senior debt fund | Schroders Capital is today announcing that it has raised €335 million for its Schroder Euro IG Infra Debt Fund V (Fund V).
Fund V, which is managed by Schroders Capital's specialist infrastructure team, aims to invest in European investment... |
